---
title: 'A multidisciplinary team and patient perspective on omission of surgery after
  neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical
  Oncology (ESSO) Research Academy survey'
date: '2024-08-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39146663/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240816182134&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Before accepting "no surgery" after complete response to
  NST, MDTs and patients need level 1 evidence from clinical trials, access to standard
  diagnostic modalities and treatments. Patient''s fear of regretting less surgery
  need to be acknowledged and ...'
disable_comments: true
---
CONCLUSIONS: Before accepting "no surgery" after complete response to NST, MDTs and patients need level 1 evidence from clinical trials, access to standard diagnostic modalities and treatments. Patient's fear of regretting less surgery need to be acknowledged and ...